NCT02978118View on ClinicalTrials.gov

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

Active, not recruitingOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

March 7, 2017

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Carcinoma, Renal CellCarcinoma, Urothelial
Interventions
DEVICE

Immune cell and CTC detection procedures

Immune cell profiling assays (in blood and archival tumor samples) and circulating tumor cell assays (in blood samples)

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

University of Wisconsin, Madison

OTHER

lead

Duke University

OTHER